Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial

Publication | Open Access

DOI Full Paper Access

409

Citations

References

2020

Year

Kenneth H. Mayer, Jean‐Michel Molina, Melanie Thompson, Peter L. Anderson, Karam Mounzer, Joss J De Wet, Edwin DeJesus, Heiko Jessen, Robert M. Grant, Peter Ruane,

The Lancet

Preventive MedicineTreatment And PreventionMedicineAntiviral Drug DevelopmentClinical TrialsAntiviral TherapyPharmacotherapyAntiviral DrugHivPharmacologyTenofovir Disoproxil FumarateHiv Pre-exposure ProphylaxisPhase 3